| TOIIX | VIHAX | TOIIX / VIHAX | |
| Total Expense Ratio | 0.77 | 0.17 | 453% |
| Annual Report Gross Expense Ratio | 3.80 | 0.17 | 2,235% |
| Fund Existence | 8 years | 10 years | - |
| Gain YTD | 9.923 | 8.274 | 120% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 500000 | 3000 | 16,667% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 163M | 15.5B | 1% |
| Annual Yield % from dividends | 3.35 | 3.49 | 96% |
| Returns for 1 year | 56.06 | 39.62 | 141% |
| Returns for 3 years | 62.03 | 58.71 | 106% |
| Returns for 5 years | 39.68 | 63.78 | 62% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IGRO | 86.79 | 0.46 | +0.53% |
| iShares International Dividend Gr ETF | |||
| BSJU | 26.07 | -0.05 | -0.19% |
| Invesco BulletShares 2030 HY Corp Bd ETF | |||
| JMID | 28.93 | -0.18 | -0.62% |
| Janus Henderson Mid Cap Growth Alpha ETF | |||
| ABFL | 71.57 | -0.75 | -1.04% |
| Abacus FCF Leaders ETF | |||
| BBP | 81.70 | -1.16 | -1.40% |
| Virtus LifeSci Biotech Products ETF | |||